Home / Inspections / 1214674

1214674

Aspire Pharmaceuticals, Inc. — FEI 3003159106

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Facility

Other inspections at this facility

  • 1015293 (NAI Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 879027 (VAI Mon May 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 668387 (VAI Mon Jun 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions